PB

Pravin Baburao Potdar

Active Director Designated Partner DIN 11524701
DIN 11524701 First appointment Feb 2026 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pravin Baburao Potdar

Data last updated:

Pravin Baburao Potdar is a Designated Partner at Medqure Remedies Llp (since 2026). The company operates in Business Services.

DIN 11524701
Primary Designation Designated Partner
Industry Business Services
First Appointment 05 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Feb 2026Active

Board colleagues of Pravin Baburao Potdar

NameDINCompanyDesignation
Amit Chandrakant Chavan11524699Medqure Remedies LlpDesignated Partner
Rahul Shivgonda Patil10070525Medqure Remedies LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medqure Remedies Llp
Premium access

Shareholding and investment profile for Pravin Baburao Potdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravin Baburao Potdar

Pravin Baburao Potdar currently holds 1 directorship: Medqure Remedies Llp (Designated Partner, since 05 Feb 2026).

Pravin Baburao Potdar was first appointed on 05 Feb 2026 as Designated Partner at Medqure Remedies Llp.

The current boards of Pravin Baburao Potdar's companies include Amit Chandrakant Chavan (Medqure Remedies Llp), Rahul Shivgonda Patil (Medqure Remedies Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available